Equibles does not estimate personal net worth.
Get an email with a short summary when NRX Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get NRXP alertsMichael Abrams is recorded as CFO at NRX Pharmaceuticals, Inc. (NRXP). The newest filing on record that lists Michael Abrams as CFO at NRX Pharmaceuticals, Inc. (NRXP) is dated February 23, 2026. NRX Pharmaceuticals, Inc. reported in an 8-K filed November 20, 2024 that Michael Abrams was appointed Chief Financial Officer, effective November 18, 2024. Michael Abrams has spoken on 8 earnings calls across 1 company, most recently for NRX Pharmaceuticals, Inc. on August 17, 2026. NRX Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NRX Pharmaceuticals, Inc. includes Jonathan C. Javitt (CEO, Chairman and Board Member), Jonathan Javitt (CEO and Chairman), Stephen Willard (CEO) and 7 others.
“On November 18, 2024, NRx Pharmaceuticals, Inc. (the “Company”) issued a press release announcing the appointment of Michael Abrams as the Chief Financial Officer of the Company.”
“For the six months ended June 30, 2026, NRX reported a net loss of $18 million versus a net loss of $23.1 million during the comparable period in 2025.”
“For the three months ended March 31st, 2026, Center X Pharmaceuticals reported a net loss of approximately $1.4 million, or $0.04 per share, as compared to a net loss of approximately $5.5 million, or $0.34 per share for the three months ended March 31st, 2025, representing a 74% year-over-year reduction.”
“Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under the United States Federal Securities Laws.”
“For the three months ended September 30, 2025, the company reported a loss of operations of $4 million versus a loss of operations of $3 million for the comparable quarter in 2024.”
Start not stated–present
Last confirmed February 23, 2026
Biotechnology · Healthcare
CFO
